Thyroid Eye Disease Diagnosis
Thyroid Eye Disease Diagnosis
Thyroid eye disease is diagnosed from the history and the examination, and the tests that follow exist to answer two questions that are often mistaken for one. The first is how active the disease is: whether the orbital tissues are inflamed now, which decides whether immunosuppressive treatment has anything to work on. The second is how much structure has already changed: how far the eye protrudes, how retracted the lids are, whether the eye closes, and whether the muscles move the two eyes together. Alongside both sits the answer that overrides them: what the disease is doing to the optic nerve. Because compression can develop without pain and without the eye looking any different, acuity, colour vision, pupil reactions and visual fields are recorded at every visit. The result of a good assessment is not the word diagnosis but a statement of activity, of severity, of the state of the optic nerve and of what should happen next.
Clinical diagnosis: recognising the pattern
This is a diagnosis made at the slit lamp and in conversation, by pattern recognition rather than by a laboratory result:
- Lid retraction is the most telling single sign. The upper lid sits higher than it should, exposing more of the eye than the opposite side. Where it is present with a visible bulge and no other explanation, the diagnosis is largely made.
- Both eyes are involved, but unequally. Asymmetry is expected rather than suspicious; a strictly one-sided picture is not a reason to exclude the disease, though it is a reason to look for other causes.
- The course is measured in months and changes. A condition that has evolved over weeks to months, with symptoms that vary, fits this disease better than one that appeared suddenly and then stayed exactly the same.
- Thyroid history is supporting evidence, not a requirement. A known thyroid problem strengthens the diagnosis, and its absence — including entirely normal blood tests — does not weaken it.
Why the diagnosis is deliberately clinical. There is no blood test that confirms thyroid eye disease and no scan required to make it. The pattern is the diagnosis, and the investigations chosen afterwards answer the two questions that change treatment.
Activity: is the disease inflamed right now?
Activity is the judgement that decides whether medication has a role, and it is scored rather than estimated:
- A structured score records the signs of inflammation. Spontaneous ache behind the eye, pain on eye movement, redness of the lids, redness of the surface, swelling of the lids, swelling of the caruncle and worsening of any of these over the preceding weeks are each recorded.
- The score is a snapshot, not a severity scale. It answers whether the disease is active today. A high score with a modest bulge is a very different situation from a low score with a marked bulge — and the treatment of the two differs completely.
- It is repeated to be useful. One score describes today; two scores describe a direction. Assessments are recorded in the same way at each visit so that the disease can be seen to be settling or progressing rather than guessed at.
Why activity is the hinge of the whole plan. Immunosuppressive treatment reduces inflammation. In an active eye that is a meaningful gain, bought at the cost of real side effects. In a quiet eye it offers nothing and costs the same. The activity score is what keeps treatment from being given for a photograph of the past rather than for the disease in front of it.
CT and MRI: what the scans show, and when they are used
Imaging is not part of a routine visit; it is requested for three specific purposes:
- To settle an uncertain diagnosis. Enlarged muscle bellies with sparing of the tendons, and an increase in orbital fat, are the characteristic picture and distinguish this disease from other causes of a bulging or inflamed orbit.
- To look for a threat to the optic nerve. Where vision, colour vision or the visual field has changed, imaging shows whether the nerve is being compressed at the back of the orbit and how crowded the space around it has become.
- To plan surgery. A decompression operation is planned from the scan: which walls to remove, how much fat to take and where the nerve and the muscles lie. Operating on an orbit that has not been imaged is not done.
What the scans cannot do. They measure structure, and structure is not activity. A scan showing enlarged muscles cannot say whether the disease is inflamed today, which is why imaging sits beside the activity score rather than replacing it.
Thyroid function and antibodies: the link, not the diagnosis
Blood tests are taken in every patient, and their role is worth stating exactly:
- They find a thyroid problem that needs treating. Most patients with thyroid eye disease have Graves’ disease, an underactive thyroid or a phase of altered function; identifying and stabilising it is part of the plan.
- They do not confirm the eye disease. Normal thyroid function tests are common in thyroid eye disease and do not exclude it. Treating the eye accordingly is not a matter of waiting for the bloods to change.
- Antibody tests add context. Thyroid-stimulating antibodies support the diagnosis and are associated with a more active course in some patients; they are read alongside the clinical picture rather than on their own.
- Stability matters as much as level. Function that swings up and down is associated with a more difficult eye course, so the aim is a settled result rather than a particular number on one day.
Why the endocrine and eye assessments belong together. The plan for the thyroid affects the eye — including the choice of how an overactive gland is treated — and the activity of the eye affects how aggressively the thyroid is managed. Reviewing them in one place is not a convenience; it is part of the treatment.
Vision, colour and fields: the one test that overrides everything
A short set of measurements is repeated at every visit, because the finding it detects can be present while everything else looks unchanged:
- Acuity in each eye. Measured separately and recorded, since a change in one eye is easy to miss when both are used together.
- Colour vision. Desaturation — colours looking washed out in one eye — is one of the earliest signs of optic nerve compression and is tested rather than asked about.
- Visual fields. A defect can be present before a patient notices a shadow, and field testing detects it while it is still reversible.
- Pupil reactions and examination of the nerve. A pupil that responds sluggishly, or a nerve head that looks swollen, supports the finding and adds urgency.
- Optic nerve scanning in selected patients. Optical coherence tomography measures the nerve fibres and can show swelling or loss over time, giving the follow-up a number to compare.
Why this section is short and urgent. Every other measurement here can be repeated next month; a change here is the one that moves the timescale to days, and the treatments that rescue the optic nerve work best the sooner they start.
From findings to a written plan
The assessment closes by turning measurements into a statement that can be acted on:
- Activity, stated plainly. Whether the disease is inflamed now, so that the question of immunosuppressive treatment can be answered rather than deferred.
- Severity, measured rather than described. Protrusion, lid position, whether the eye closes, and the alignment of the two eyes — recorded as numbers that a later comparison can use.
- The state of the optic nerve. Acuity, colour, fields and the appearance of the nerve, with a note of what would constitute a change worth reporting immediately.
- The thyroid plan alongside it. What the blood tests showed, what is being done about them, and how stability is being pursued.
What a complete assessment looks like. A diagnosis supported by the pattern, an activity score, measurements of structure for each eye, documented vision, and a written interval with a list of symptoms that would bring the next review forward. Four items, all of which travel.